Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention? Journal Article


Authors: Spanknebel, K. A.; Brennan, M. F.
Article Title: Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention?
Abstract: The extent of lymphadenectomy for gastric cancer is a controversial topic widely debated by those treating the disease. Regionaly differences in outcome have been noted between patients treated in Japan centers and those treated in Western centers. Technical differences have been investigated within the context of two large, prospective randomized trials, which found no benefit to more extensive lymphadenectomy procedures with increased morbidity. Subsets of patients being treated for cure may benefit from extended resections. The impact of tumor features, such as depth of invasion and number of metastatic lymph nodes, has been described and incorporated into current staging systems. The role of enhanced pathologic evaluation of surgical specimens and impact on staging and treatment strategies is evolving.
Keywords: immunohistochemistry; treatment outcome; mortality; review; disease classification; cancer staging; follow up; lymph node metastasis; lymph node dissection; neoplasm staging; lymph node excision; lymphadenectomy; quality control; pathology; cancer invasion; early diagnosis; patient compliance; stomach cancer; stomach neoplasms; stomach tumor; humans; prognosis; human
Journal Title: Surgical Oncology Clinics of North America
Volume: 11
Issue: 2
ISSN: 1055-3207
Publisher: Elsevier Inc.  
Date Published: 2002-04-01
Start Page: 415
End Page: 430
Language: English
DOI: 10.1016/s1055-3207(02)00008-x
PUBMED: 12424860
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 14 November 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Murray F Brennan
    1059 Brennan